These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. A comparison of ampicillin/sulbactam and cefoxitin in the treatment of bacterial skin and skin-structure infections. Weigelt JA. Adv Ther; 1994 Feb; 11(4):183-91. PubMed ID: 10150262 [Abstract] [Full Text] [Related]
14. Therapeutic interchange of ampicillin-sulbactam for cefoxitin. Lawrenz CA, Cole P, Theodorou A, Cook RL, Bermann L. Am J Hosp Pharm; 1991 Oct; 48(10):2150-4. PubMed ID: 1781470 [Abstract] [Full Text] [Related]
16. Comparison of cefoxitin, cefotetan and the combination of ampicillin with sulbactam in the therapy of polymicrobial infection in mice. Brook I. J Antimicrob Chemother; 1994 Nov; 34(5):791-6. PubMed ID: 7706175 [Abstract] [Full Text] [Related]
17. Efficacy of ampicillin-sulbactam versus that of cefoxitin for treatment of Escherichia coli infections in a rat intra-abdominal abscess model. Rice LB, Carias LL, Shlaes DM. Antimicrob Agents Chemother; 1993 Mar; 37(3):610-2. PubMed ID: 8460928 [Abstract] [Full Text] [Related]
18. Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections. Falagas ME, Barefoot L, Griffith J, Ruthazar R, Snydman DR. Eur J Clin Microbiol Infect Dis; 1996 Dec; 15(12):913-21. PubMed ID: 9031873 [Abstract] [Full Text] [Related]
19. Ampicillin/sulbactam and cefoxitin in the treatment of cutaneous and other soft-tissue abscesses in patients with or without histories of injection drug abuse. Talan DA, Summanen PH, Finegold SM. Clin Infect Dis; 2000 Aug; 31(2):464-71. PubMed ID: 10987706 [Abstract] [Full Text] [Related]